Lucis has announced it has closed a US$8.5 million seed funding round led by General Catalyst, with participation from Y Combinator, Kima Ventures, Motier Ventures, Circle.Co, and North South Ventures.
The funding will enable the startup to accelerate its rollout in France, the UK, Ireland and Portugal, as well as in new markets, expand its network of partner laboratories and physicians, and continue expanding its AI-powered preventive analysis and support platform.
Maxime Berthelot is CEO and co-founder of Lucis.
Berthelot said: “Our mission is to empower individuals to take ownership of their health by giving them a clear view of key indicators before symptoms even appear, and providing practical guidance to improve their well-being, without replacing physicians.”
Lucis positions itself as a preventive tool for individuals, helping them better understand their health status.
Members undergo their health check-ups in certified medical biology laboratories across Europe.
Results are analysed by a multidisciplinary medical team, with AI used to prioritise key signals and track their evolution over time.
Each member gains access to a dashboard and a prioritised action plan built around five pillars: nutrition, supplements, physical activity, sleep/recovery, and mental health.
Berthelot said: “At a time when more and more Europeans are looking to take control of their health and feel better overall, this funding round will allow us to democratise access to disease prevention by connecting analyses conducted in certified laboratories, medical expertise, and a simple, user-friendly platform.”
